Pfizer's Intellectual Property Rights Battles in China for Viagra
Pfizer Wins Viagra IPR Litigation - China In Transition?
Analysts saw these incidents as some of the successes achieved by Pfizer in its efforts to thwart the challenge posed by manufacturers of generic and fake drugs in a country that was known to offer weak intellectual property rights (IPR) protection.Many also saw these rulings as an indication of China's increasing commitment to provide adequate IPR protection in order to conform to the Trade Related Intellectual-Property Rights (TRIPS)6 agreements......
Pfizer's Intellectual Property Rights Battles in China for Viagra Cond..- Next Page>>